Additionally, GLP-1 and its agonists have been shown to promote cardiovascular protection after myocardial infarction, congestive heart failure, and ischemia, as well as have protective effects on various cardiovascular diseases and conditions, such as hypertension, atherosclerosis, and myocardial hypertrophy [148]. This evidence concerns the gene GCG and cardiac hypertrophy.